Article Figures & Data
Figures
- Figure 1.
APPROACH Primary Endpoint – Change in PAV.
Tools
No Significant Benefit with Rosiglitazone in Preventing Progression of Atherosclerosis in Diabetic Patients with a History of Cardiovascular Disease
Permalink:
Table of contents
Cited By...
- No citing articles found.